Form 4: Embecta Corp. Executive Mann Reports Stock Transactions

Jeffrey Z. Mann, a senior executive at Embecta Corp., reported the acquisition and disposal of company stock on November 26, 2024, including shares withheld for taxes.

Summary

• Jeffrey Z. Mann, SVP, GC, Head Corp. Dev., and Secretary at Embecta Corp., reported changes in his beneficial ownership of company stock.
• On November 26, 2024, Mann acquired 50,803 shares of common stock at $0.00, likely through the vesting of restricted stock units.
• Also on November 26, 2024, 8,016 shares were disposed of at $18.70 per share to cover withholding taxes related to the vesting of the restricted stock units.
• Following these transactions, Mann's total direct holdings of common stock are 142,568.298 shares, which includes shares received as stock dividends.

Sentiment

Score: 7

Explanation: The document reflects routine transactions related to executive compensation and tax obligations. There is no indication of positive or negative sentiment, it is a neutral event.

Positives

• The acquisition of 50,803 shares indicates an increase in Mann's stake in the company.
• The vesting of restricted stock units suggests that Mann is meeting performance or tenure requirements.

Negatives

• The disposal of 8,016 shares, while for tax purposes, reduces Mann's overall holdings.

Risks

• The sale of shares to cover taxes could be perceived negatively by some investors, although it is a common practice.
• Significant changes in executive holdings could sometimes signal internal shifts or concerns, though this transaction appears routine.

Industry Context

This is a standard SEC Form 4 filing, which is a routine disclosure for corporate insiders. It does not indicate any unusual activity or trends within the medical device industry.

Comparison to Industry Standards

• Form 4 filings are a standard practice for publicly traded companies, and this filing is consistent with those of other companies in the medical device sector.
• The transactions are typical for executives receiving stock-based compensation and managing tax obligations.

Stakeholder Impact

• The transactions have a minimal impact on shareholders, as they are routine and do not indicate any significant change in the company's financial health or outlook.
• The transactions are not expected to impact employees, customers, suppliers, or creditors.

Key Dates

Keywords

Embecta Corp, stock ownership, insider trading, Form 4, executive compensation, restricted stock units, Jeffrey Z. Mann